Editas Medicine

Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust

Editas Medicine sent this email to their subscribers on October 4, 2024.

October 3, 2024 6:00 PM EDT

Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust

View this release →

Or click here to view all releases.

Text-only version of this email

Editas Medicine, Inc October 3, 2024 6:00 PM EDT Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust View this release → Or click here to view all releases.

Show all

The Latest Emails Sent By Editas Medicine

New Form 8-K for Editas Medicine, Inc

New Form 8-K for Editas Medicine, Inc

Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities

Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities

Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference

New Form 8-K for Editas Medicine, Inc

New Form 8-K for Editas Medicine, Inc

New Form 8-K for Editas Medicine, Inc

New Form 8-K for Editas Medicine, Inc

Editas Medicine Announces Strategic Transition to in vivo Gene Editing Company with Intent to Achieve Human Proof of Concept in Approximately Two Years

Editas Medicine Announces Strategic Transition to in vivo Gene Editing Company with Intent to Achieve Human Proof of Concept in Approximately Two Years